Timothy Ritzmann

NIHR Academic Clinical Lecturer in Paediatric Oncology

University of Nottingham

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Timothy Ritzmann is an NIHR Academic Clinical Lecturer in Paediatric Oncology at the University of Nottingham, UK. His research focuses on improving diagnosis and treatment strategies for pediatric ependymoma and other childhood cancers. Recent publications highlight advancements in diagnostic processes, biomarker optimization, and the clinical outcomes of young patients with brain tumors.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Eric Prince

Professional Research Assistant

University of Colorado School of Medicine

UNITED STATES

View details

Siddhartha Mitra

Assistant Professor

University of Colorado School of Medicine

UNITED STATES

View details

Denise Obrecht-Sturm

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Judith Ramage

Associate Professor

University of Nottingham

UNITED KINGDOM

View details

Andrew M Donson

University of Denver

UNITED STATES

View details

Madhumita Dandapani

Clinical Associate Professor of Paediatric Oncology

University of Nottingham

UNITED KINGDOM

View details

Kavita Vedhara

Professor

Cardiff University

UNITED KINGDOM

View details

Jacques Grill

Head day care

Gustave Roussy

FRANCE

View details

Dexiang Gao

Associate Professor

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Timothy Ritzmann

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Quantifying diagnostic intervals and routes to diagnosis for children and young people with cancer in the UK (Childhood Cancer Diagnosis study, CCD): a population-based observational study

European standard clinical practice recommendations for newly diagnosed ependymoma of childhood and adolescence

Neither Small Adults nor Big Children: Doing Better for TYAs with Brain Tumors

Cognitive Outcomes in Children Treated for Ependymoma Diagnosed Under 36 Months: A Systematic Review

A review calling for research directed at early detection of childhood cancers: The clinical, scientific, and economic arguments for population screening and surveillance

Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study

Multi-Omic approach identifies hypoxic tumor-associated myeloid cells that drive immunobiology of high risk pediatric ependymoma

Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study

Spatial transcriptomic analysis delineates epithelial and mesenchymal subpopulations and transition stages in childhood ependymoma.

Toward Improved Diagnosis Accuracy and Treatment of Children, Adolescents, and Young Adults With Ependymoma: The International SIOP Ependymoma II Protocol

Recurrent ACVR1 mutations in posterior fossa ependymoma

SIOP Ependymoma I: Final results, long term follow-up and molecular analysis of the trial cohort: A BIOMECA Consortium Study

Phase II study of intravenous etoposide in patients with relapsed ependymoma (CNS 2001 04)

Multicentre service evaluation of presentation of newly diagnosed cancers and type 1 diabetes in children in the UK during the COVID-19 pandemic.

EPEN-04. SIOP EPENDYMOMA I: FINAL RESULTS, LONG TERM FOLLOW-UP AND MOLECULAR ANALYSIS OF THE TRIAL COHORT: A BIOMECA CONSORTIUM STUDY

EPEN-07. SINGLE-CELL RNA SEQUENCING IDENTIFIES A UNIQUE MYELOID SUBPOPULATION ASSOCIATED WITH MESENCHYMAL TUMOR SUBPOPULATION IN POOR OUTCOME PEDIATRIC EPENDYMOMA

EPEN-08. THE TREM1 POSITIVE HYPOXIC MYELOID SUBPOPULATION IN POSTERIOR FOSSA EPENDYMOMA

EPEN-11. TUMOR DIFFERENTIATION IMPACTS THE BIOLOGY OF RECURRENCE IN CHILDHOOD POSTERIOR FOSSA EPENDYMOMA

Collaborators (9)

Eric Prince

Siddhartha Mitra

Denise Obrecht-Sturm

Judith Ramage

Andrew M Donson

Madhumita Dandapani

Kavita Vedhara

Jacques Grill

Dexiang Gao

Make your next move.